⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2000Endocrine Research

Gene Dosage Effects of Steroidogenic Factor 1 (SF-1) in Adrenal Development and the Stress

Michelle L. Bland Christine Jamieson Susan Akana Mary F. Dallman Holly A. Ingraham

View at Publisher

Ask AI

Bookmark

Share

Abstract

"Gene Dosage Effects of Steroidogenic Factor 1 (SF-1) in Adrenal Development and the Stress." Endocrine Research, 26(4), pp. 515–516

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bland et al. (2000) studied this question.

synapsesocial.com/papers/6a87bfff3bdf89560ead2b7a https://doi.org/10.3109/07435800009048563

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Study of the rapid vasodilating effect induced by 5β-dihydrotestosterone in the isolated pulmonary arteries of female and male ratsEndocrine Research · Wed,
2Sortilin Immunoreactivity Is Associated with Lymphatic and Extrathyroidal Invasion in Medullary Thyroid Carcinoma: A Preliminary Single-Center StudyEndocrine Research · Wed,
3Exploring the SPARAGMOS Study Protocol: review of a high-dose cabergoline interventional trial in microprolactinomasEndocrine Research · Thu,
4Association of serum fibroblast growth factor 19 with DKD as assessed by the UACR and eGFR in patients with type 2 diabetesEndocrine Research · Tue,
5Efficacy of L-Arginine, Myoinositol, and Chromium with Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome: A Randomized Comparative StudyEndocrine Research · Mon,

More from Endocrine Research

Clinical insights from diagnosis to outcomes in pediatric hypoparathyroidism and inactivating PTH/PTHrP signaling disordersThu,
The interaction between eGDR and visceral adiposity in renal function decline among middle-aged and elderly diabetes patients: findings from a nationwide Chinese cohortMon,
Impact of antithyroid drug duration on radioactive iodine therapy efficacy in Graves’ disease in Japan: a propensity score-matched analysis using thyroid weight-based outcomesThu,
MMRN1 suppresses thyroid cancer progression via activation of the Hippo signaling pathwayTue,
Body composition and cardiometabolic changes during gender-affirming hormone therapy: 12-month longitudinal studyFri,